Form 10-Q · Quarterly report
Advanced Micro Devices 10-Q, filed Aug 5, 2026
- Filed
- CIK
- 0000002488
- Accession no.
- 0000002488-26-000123
Summary
Advanced Micro Devices reported net revenue of $11.5 billion for the quarter ended June 27, 2026, a 50% year-over-year increase, with net income of $2.3 billion and operating income of $2.0 billion. The company also disclosed multi-year agreements under which OpenAI and Meta Platforms each intend to deploy up to 6 gigawatts of AMD data center GPUs, with warrants for up to 160 million shares each at $0.01 per share.
Key points
- Data Center segment net revenue rose to $6.718 billion for the quarter from $3.240 billion a year earlier, driven by EPYC processors and Instinct MI350 series GPUs.
- Gross margin was 54%, compared with 40% a year earlier, primarily due to the absence of prior-year inventory charges tied to U.S. export controls on Instinct MI308 GPUs and a favorable product mix.
- Cash, cash equivalents and short-term investments were $13.1 billion as of June 27, 2026, compared with $10.6 billion as of December 27, 2025.
- The first gigawatt of each OpenAI and Meta deployment is to be powered by AMD Instinct MI450 series products; as of June 27, 2026, no warrant tranches had vested or become exercisable.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS The statements in this report include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on current expectations and beliefs and involve numerous risks and uncertainties that could cause actual results to differ materially from expectations. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.